The Opportunity:

We are currently recruiting for an experienced, dynamic and visionary Senior Director of Cardiovascular & Renal Global Commercial Development to join our team.

This pivotal role will serve as the commercial voice within the R&D Product Strategy Team (PST), driving Early Product Strategy, Target Product Profiles & Claims (TPPs/TPCs), Market Shaping, Product Positioning, Stakeholder Engagement, Stage-Gate Preparation, Value Proposition and Life Cycle Management (LCM) Planning and Execution across multiple indications.

The successful candidate will contribute to the therapeutic area (TA) strategy and execution to maximize long-term asset value, optimize portfolio balance, and identify opportunities for inorganic growth.

The Role:

Commercial Leadership:

• Define the commercial direction for a new MOA and new disease areas at CSL.

• Lead a co-development/co-promotion cross-company partnership.

• Act as the primary commercial representative in the R&D Product Strategy Team (PST), influencing early product strategy, TPPs, TPCs, Stage-Gate Preparation, and LCM Planning and Execution.

Product Strategy and Execution:

• Lead the development and execution of the multi-indication Product Strategy to drive long-term asset value and optimize product profile.

• Drive cross-indication accountability and leadership.

Inorganic Growth:

• Lead cross-functional assessments of prioritized indications, assets, technologies and MOA’s from the external environment, identifying and evaluating these opportunities for inorganic growth, including partnerships, acquisitions, and collaborations.

• Conduct data-driven commercial diligence and drive successful business development financial cases.

Cross-Functional Collaboration:

• Collaborate with functional and regional partners (e.g., Market Access, Insights and Analytics, US and International) to present a unified commercial voice in PSTs, TALTs, and other teams, influencing strategy and investment decisions.

• Deliver a positive impact on portfolio investment and resource allocation decisions.

Portfolio Optimization:

• Influence on overall CVR strategy and future asset value creation. Drive multi-indication accountability and leadership.

• Ensure a balanced portfolio by managing assets across various disease areas and risk profiles, leveraging both internal and external opportunities.

• Drive cross-indication accountability and leadership.

Strategic Influence:

• Define and drive the asset strategy, ensuring alignment with overall business objectives and market needs.

Skills and Experience:

• Advanced degree in Business, Life Sciences, or a related field.

• 15+ years of experience in commercial development, strategy and/or analytics within the pharmaceutical or biotechnology industry, specifically in Cardiology and/or Nephrology.

• Proven track record of leading cross-functional teams and driving strategic initiatives.

• Strong analytical and strategic thinking skills, with the ability to influence and drive decision-making.

• Expertise in leading commercial assessments of external opportunities with prior experience in BD+L/M&A, analytics, consulting and/or commercial strategy.

• Excellent communication and collaboration skills, with the ability to work effectively with global teams.

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.

Our Benefits

For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.

You Belong at CSL

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.

To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging

Equal Opportunity Employer

CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.